In the pharmaceutical industry, ensuring drug safety and efficacy is non-negotiable. A critical component of this assurance lies in identifying and quantifying Atovaquone impurities — unwanted chemicals that may arise during synthesis, formulation, or storage. These impurities can af

In the field of pharmaceutical development and quality control, the identification and characterization of drug impurities are crucial. One such active pharmaceutical ingredient (API) that requires rigorous impurity profiling is Atovaquone, commonly used for treating pneumocystis pneumonia and

In the realm of pharmaceutical research, particularly in the study and synthesis of antimalarial and antiparasitic agents, Deschloro Atovaquone stands out as a crucial intermediate. With its structural resemblance to atovaquone — a widely used antiparasitic drug — Deschloro Ato